NM
SRPT icon

Nokota Management’s Sarepta Therapeutics SRPT Stock Holding History

Nokota Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-80,020
Closed -$5.93M – 104
2018
Q1 		$5.93M Hold
80,020
– – 0.08% 84
2017
Q4 		$4.45M Hold
80,020
– – 0.09% 70
2017
Q3 		$3.63M Sell
80,020
-40,457
-34% -$1.62M 0.09% 65
2017
Q2 		$4.06M Buy
+120,477
New +$3.92M 0.12% 61

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Nokota Management's SRPT Position: Q2 2018 in Review

Nokota Management sold out of Sarepta Therapeutics (SRPT) in Q2 2018, closing a stake of 80,020 shares — an estimated $5.93M sold.

Nokota Management first reported a position in SRPT in Q2 2017 and held it in 4 quarters. The position peaked at $5.93M in Q1 2018. 317 funds tracked by Wall St. Rank hold SRPT as of Q2 2018.

  • Nokota Management reported no remaining Sarepta Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Nokota Management sold 80,020 Sarepta Therapeutics shares in Q2 2018, an estimated $5.93M.
  • Nokota Management first reported a position in Sarepta Therapeutics in Q2 2017 and held it in 4 quarters.
  • Nokota Management's Sarepta Therapeutics position peaked at $5.93M in Q1 2018.
  • 317 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2018.

Based on Nokota Management's 13F filing for Q2 2018, filed 14 Aug 2018.